Mendu Appointed Associate Chief Medical Officer

Mallika Mendu, MD, MBA, has been named the Brigham’s new associate chief medical officer (ACMO) effective Tuesday, March 1.

As ACMO, Mendu will be the physician leader focusing on Care Continuum Management, Inpatient Operations and Population Health. In this role, she will be responsible for leading the transformation of care delivery at BWH in these areas and collaborating closely with leadership at the Brigham and across Mass General Brigham. She will also join the existing ACMOs to lead efforts in professionalism, credentialing and operations.

Mendu has been at the Brigham since 2009 and currently serves in the Department of Medicine, Renal Division, as a practicing nephrologist, clinical researcher and assistant professor, and has gained national recognition for her research related to kidney care delivery innovation. She also serves as the executive medical director for Clinical Operations for the Brigham, and in this role, has led multidisciplinary efforts to optimize care continuum management and inpatient operations. She has also been a medical director of Mass General Brigham Population Health Management for the past seven years, where she has led specialty efforts and care management programs. Mendu completed her internal medicine residency at BWH, her nephrology training at BWH and Massachusetts General Hospital, and her MD and MBA degrees at the Yale School of Medicine and the Yale School of Management, respectively.

In her new role as ACMO, Mendu will report to Sunil Eappen, MD, as chief medical officer for professional matters and clinical responsibilities; to Maddy Pearson, DNP, RN, NEA-BC, senior vice president, Patient Care Services, and chief nursing officer, for Care Continuum Management; and to Bernie Jones, EdM, vice president of Value-Based Care, Public Policy, and Administrative Operations, for Value-Based Care and Population Health.

Louis Appointed Mass General Brigham Chief of Enterprise Pathology

David Louis, MD, has been appointed Mass General Brigham chief of Enterprise Pathology and will oversee the new enterprise service, Mass General Brigham enterprise laboratory service (MGBELS). Louis will continue to serve as chief of the Department of Pathology at Massachusetts General Hospital, where he has led the department to become a national leader in molecular diagnostics and pathology informatics. He will also assume the role of chair of the Department of Pathology at Brigham and Women’s Hospital on March 1.

Louis is the Benjamin Castleman Professor of Pathology at Harvard Medical School and a renowned leader in diagnostic pathology. His research on brain tumors and the application of molecular diagnostics to glioma classification has contributed to the worldwide adoption of molecular testing for the management of glioma patients. In addition, Louis has led multiple international efforts to modernize and standardize brain tumor classification, including those of the World Health Organization over the past 15 years.

In his new role, Louis will work closely with clinical and administrative leadership across Mass General Brigham to build one innovative, high-quality enterprise service. This streamlined approach to patient care and diagnostic protocols across all of our locations will enable us to provide the highest-quality and most cutting-edge clinical laboratory testing and pathology services for all Mass General Brigham patients.

New, Notable and Transitions.

  • Stephanie Kayden, MD, MPH, has been appointed deputy chair of the Department of Emergency Medicine.
  • Trancy Escobar has been appointed executive director of Complex Care Management and Post-Acute Strategy, effective immediately.
  • Jean Jackson, SPHR, SHRM-SCP, vice president of Human Resources, is leaving the Brigham effective Friday, March 11.

Home